DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lemalesomab
Lemalesomab
Modifications to the Harmonized Tariff Schedule of the United States To
The Two Tontti Tudiul Lui Hi Ha Unit
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
I Regulations
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Wo 2016/061562 A2 ©
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
WHO Drug Information Vol
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
WO 2013/093809 Al 27 June 2013 (27.06.2013) P O P C T
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Customs Tariff - Schedule
Assessment of the Evolution of Cancer Treatment Therapies
Top View
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
WO 2017/148880 Al 8 September 2017 (08.09.2017) P O P C T
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
Q:\Users\Brendac\Pharmaceutical Zeroforzero Initiative FINAL Edited
Assessment of the Evolution of Cancer Treatment Therapies
International Nonproprietary Names (INN) for Biological and Biotechnological Substances